April 23, 2020 - Assignment

Enginzyme completes series A financing

The Swedish biotechnology company EnginZyme AB has completed its Series A financing round, led by the life science VC Sofinnova Partners. The funds raised will primarily be used for further development and commercialization of the company's technology platform.

EnginZyme was advised by Mannheimer Swartling in the transaction.